STOCK TITAN

Enact Holdings (ACT) Form 4 Filings

ACT NASDAQ

Here are the Form 4 insider transactions from Enact Holdings, Inc. (ACT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACT filings page.

Rhea-AI Summary

Enact Holdings, Inc. disclosed that an officer serving as EVP, CFO and Treasurer acquired additional restricted stock units on December 11, 2025 through dividend reinvestment features in existing awards. On that date, the officer received 38, 67 and 81 restricted stock units at a price of $0.00 each, tied to a quarterly dividend of $0.21 per share paid on December 11, 2025.

Each restricted stock unit will settle into one share of Enact common stock. The related awards vest and convert to common stock in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026. Following these transactions, the officer beneficially owned 7,095, 12,512 and 15,196 restricted stock units across the respective grants.

Rhea-AI Summary

Enact Holdings, Inc. reported an insider equity transaction by its EVP, General Counsel & Secretary. On December 11, 2025, the executive acquired additional restricted stock units (RSUs) in three separate awards of 17, 27, and 33 units, all at a price of $0 per unit.

Each RSU will settle into one share of Enact common stock. The filing explains that these extra RSUs were credited under the award agreements’ reinvestment terms based on a quarterly dividend of $0.21 per share paid on December 11, 2025. The related RSU awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025, and February 21, 2026, and the executive now directly holds 3,170, 5,006, and 6,080 RSUs under these grants.

Rhea-AI Summary

Enact Holdings, Inc. reported an insider equity transaction involving deferred stock units for one of its directors. On December 11, 2025, the director acquired 165 deferred stock units linked to Enact common stock.

The award arose from dividend reinvestment under the director award agreement, based on a dividend of $0.21 per share paid on that date. Following this transaction, the director beneficially owns 30,543.457 deferred stock units.

Rhea-AI Summary

Enact Holdings, Inc. reported an insider transaction by a director involving deferred stock units linked to company dividends. On 12/11/2025, the director acquired 165 deferred stock units under a director award agreement through reinvestment of a cash dividend paid at $0.21 per share.

Following this transaction, the director beneficially owns a total of 30,543.457 deferred stock units on a direct basis. These deferred stock units become payable in shares of Enact Holdings common stock one year after the director’s service on the board ends.

Rhea-AI Summary

Enact Holdings, Inc. (ACT) disclosed a Form 4 showing that a company director sold Enact common stock in two transactions. On 11/18/2025, the director sold 2,562 shares of common stock at a weighted average price of $37.411 per share as part of a series of broker-assisted sales ranging from $37.39 to $37.44 per share. On 11/19/2025, the director sold an additional 7,438 shares at $37.39 per share. After these sales, the director reported owning 5,000 shares of Enact common stock directly.